Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Manuel, Baca Cots"'
Autor:
Eric A F Simões, Shabir A Madhi, William J Muller, Victoria Atanasova, Miroslava Bosheva, Fernando Cabañas, Manuel Baca Cots, Joseph B Domachowske, Maria L Garcia-Garcia, Ineta Grantina, Kim A Nguyen, Heather J Zar, Anna Berglind, Celeste Cummings, M Pamela Griffin, Therese Takas, Yuan Yuan, Ulrika Wählby Hamrén, Amanda Leach, Tonya Villafana
Publikováno v:
The Lancet Child & Adolescent Health. 7:180-189
Autor:
Laura L, Hammitt, Ron, Dagan, Yuan, Yuan, Manuel, Baca Cots, Miroslava, Bosheva, Shabir A, Madhi, William J, Muller, Heather J, Zar, Dennis, Brooks, Amy, Grenham, Ulrika, Wählby Hamrén, Vaishali S, Mankad, Pin, Ren, Therese, Takas, Michael E, Abram, Amanda, Leach, M Pamela, Griffin, Tonya, Villafana, Jon, Heinrichs
Publikováno v:
New England Journal of Medicine. 386:837-846
BACKGROUND: Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infection and hospitalization in infants. Nirsevimab is a monoclonal antibody to the RSV fusion protein that has an extended half-life. The efficacy and safety
Autor:
Laura Hammitt, Ron Dagan, Yuan Yuan, Manuel Baca Cots, Miroslava Bosheva, Shabhir A Mahdi, William J Muller, Heather J Zar, Dennis Brooks, Amy Grenham, Ulrika Wählby Hamrén, Vaishali S Mankad, Pin Ren, Therese Takas, Jon Heinrichs, Amanda Leach, M Pamela Griffin, Tonya L Villafana
Publikováno v:
Open Forum Infectious Diseases
Background Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infection (LRTI) in infants. Nirsevimab is a single-dose monoclonal antibody with extended half-life that was shown to protect preterm infants 29 to < 35